New inhaled treatment tested for deadly lung pressure complication
Disease control
Not yet recruiting
This study is testing whether an inhaled medication called L606 can help people with high blood pressure in their lungs caused by lung scarring (interstitial lung disease). Researchers will measure if participants can walk farther and if the treatment delays worsening of their co…
Phase: PHASE3 • Sponsor: Liquidia Technologies, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC